These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Grochowska MM, Carreras Mascaro A, Boumeester V, Natale D, Breedveld GJ, Geut H, van Cappellen WA, Boon AJW, Kievit AJA, Sammler E, Netherlands Brain Bank, Parchi P, Cortelli P, Alessi DR, van de Berg WDJ, Bonifati V, Mandemakers W. Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039 [Abstract] [Full Text] [Related]
5. TIGAR inclusion pathology is specific for Lewy body diseases. López KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR. Brain Res; 2019 Mar 01; 1706():218-223. PubMed ID: 30267647 [Abstract] [Full Text] [Related]
6. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gómez C, Ambrosio S. J Neural Transm (Vienna); 2001 Mar 01; 108(12):1383-96. PubMed ID: 11810403 [Abstract] [Full Text] [Related]
7. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. J Neuropathol Exp Neurol; 2003 Apr 01; 62(4):389-97. PubMed ID: 12722831 [Abstract] [Full Text] [Related]
9. Formation and development of Lewy pathology: a critical update. Jellinger KA. J Neurol; 2009 Aug 01; 256 Suppl 3():270-9. PubMed ID: 19711116 [Abstract] [Full Text] [Related]
12. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Seidel K, Mahlke J, Siswanto S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rüb U. Brain Pathol; 2015 Mar 01; 25(2):121-35. PubMed ID: 24995389 [Abstract] [Full Text] [Related]
13. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, Lockhart P, Zhang J. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):119-38. PubMed ID: 15790536 [Abstract] [Full Text] [Related]
14. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M. Acta Neuropathol; 2000 Sep 24; 100(3):285-90. PubMed ID: 10965798 [Abstract] [Full Text] [Related]
15. Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. Higashi S, Moore DJ, Yamamoto R, Minegishi M, Sato K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Hino H, Kosaka K, Emson PC, Wada K, Dawson VL, Dawson TM, Arai H, Iseki E. J Neuropathol Exp Neurol; 2009 Sep 24; 68(9):994-1005. PubMed ID: 19680143 [Abstract] [Full Text] [Related]
16. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T. Rinsho Shinkeigaku; 1999 Dec 24; 39(12):1285-6. PubMed ID: 10791099 [Abstract] [Full Text] [Related]
17. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. Am J Pathol; 1998 Apr 24; 152(4):879-84. PubMed ID: 9546347 [Abstract] [Full Text] [Related]
19. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease. Uchihara T. Neuropathology; 2017 Apr 24; 37(2):129-149. PubMed ID: 27862327 [Abstract] [Full Text] [Related]